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Methyl isocyanate (MIC) was tested for genetic toxicity in a variety of in vitro and in vivo assays.
Negative results were obtained in the Salmonella/mammalian microsome assay using five bacterial strains
in a preincubation protocol. The Drosophila sex-linked recessive lethal test also gave negative results in
studies that involved three routes of administration: inhalation, feeding, and injection. Positive results
were obtained for three endpoints in cultured mammalian cells. Reproducible, dose-related increases in
trifluorothymidine-resistant clones were induced in L5178Y mouse lymphoma cells, and the frequencies
of both SCE and chromosomal aberrations increased in Chinese hamster ovary cells. These effects were
independent of exogenous metabolism. In mice exposed to methyl isocyanate by inhalation, cytogenetic
analyses were carried out on bone marrow, blood, and lung cells. A single, 2-hrexposure to concentrations
of 0, 3, 10, and 30 ppm MIC produced no evidence of chromosomal effects in the bone marrow, although
significant cell cycle delay was observed. In four experiments involving exposures on 4 consecutive days
to 0, 1, 3, or 6 ppm, delays in bone marrow cell cycle were again observed. Increases in SCE and chro-
mosomal aberrations were observed in bone marrow cells, and a dose-related increase in SCE occurred in
lungcells but not in peripheral blood lymphocytes. Asignificant increase in micronucleated polychromatic
erythrocytes in the peripheral blood was observed in male mice in one experiment.
From these results, it appears that methyl isocyanate has the capacity to affect chromosome structure
but not to induce gene mutations. Furthermore, in vitro tests show that the induction of chromosomal
effects is not dependent on an exogenous source of metabolism. Based on these results and on what is
known about the binding of carbamoylating agents to cellular macromolecules, methyl isocyanate may
exert its genetic toxicity by binding to nuclear proteins rather than by binding to DNA.
Introduction
Methyl isocyanate (MIC) was assayed in a number of
in vitro and in vivo genetic toxicity tests to determine
its ability to interact with DNA and/or to induce genetic
damage. In vitro tests included the Salmonella/mam-
malian microsome test forbacterial gene mutations, the
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L5178Y mouse lymphoma cell test forthymidine kinase
mutants, and tests for chromosomal aberrations and
sister chromatid exchanges (SCE) in cultured Chinese
hamster ovary (CHO) cells. In vivo studies were con-
ducted usingthe sex-linked recessive lethal test inDro-
sophila melanogaster; tests for SCE in bone marrow,
lung, and blood cells; and tests for chromosomal aber-
rations and micronuclei in bone marrow cells of mice
exposed to MICbyinhalation. Thispaperpresents sum-
maries of test results presented elsewhere (1-4).
Results
Salmonella
The Salmonella/mammalian microsome assay was
conducted using a preincubation protocol employing
strains TA1535, TA1537, TA97, TA98, and TA100with-
outmetabolic activation and with S9 fromAroclor 1254-
induced male Sprague-Dawley rats and similarly in-SHELBY ET AL.
Table 1. Methyl isocyanate: summary of genetic toxicity test results from in vitro and Drosophila assays.
Assay Dose range Level of effect' Test result
Salmonella (- S9) 0.3-333 jig/plate No effect Negative
(+S9) 0.3-333 ,ug/plate No effect Negative
L5178Y TK+'- (-S9) 0.5-3.0 nL/mL 5x (trial 1) Positive
13x (trial 2) Positive
Methylamineb (+ S9) 50-400 nL/ML 2.4x Positive
N,NX-dimethylureab (-S9) 500-5000 j,g/mL No effect Negative
(+S9) 500-5000 ,u/mL No effect Negative
N-methylcarbamic acid,
ethyl esterb (-S9) 500-5000 nL/mL No effect Negative
(+S9) 500-5000 nL/mL 2.2x (trial 1) Positive
2.5x (trial 2) Positive
1.8x (trial 3) Positive
CHO-SCE (-S9) 0.3-3.1 j,g/mL 1.9x (trial 1) Positive
1.4 x (trial 2) Positive
(+S9) 0.3-3.1 pig/mL 1.6x Positive
CHO-CA (-S9) 10-25,g/mL 22x Positive
(+S9) 15-25 Rg/mL 30x Positive
Drosophila
(inhalation) 14 ppm in air No effect Negative
(feeding) 600 ,ug/mL in food No effect Negative
(injection) 260 ,ug/mL (trial 1) No effect Negative
350 ,ug/mL (trial 2) No effect Negative
aGreatest fold increase over the concurrent solvent control value.
bHydrolysis products of MIC.
duced Syrian hamsters. Doses, at half log intervals,
from 0.3 to 333 ,ug/plate failed to induce an increased
frequency of revertant colonies under any of the test
conditions employed. Toxicity, as evident from a thin-
ning of the background lawn ofbacteria, was noted at
the higher doses (33, 100, or 333 ,ug/plate) in all tests,
confirming that the bacteria were exposed to MIC or a
breakdown product of MIC (3).
L5178Y Mouse Lymphoma Cells
Cultured L5178Y mouse lymphoma cells were used
to test MIC for the induction of thymidine kinase mu-
tants selected for resistance to trifluorothymidine. In
the absenceofexogenousmetabolicactivation, MICwas
tested atsixdosesfrom0.5to3.0nL/mLinthemedium.
Two trials yielded reproducible, dose-related increases
in the fraction oftrifluorothymidine-resistant mutants.
In both trials, the mutant fraction at the highest dose
was more than five times that for the solvent control,
indicatingaclearmutageniceffectforMICinthisassay.
In both trials, mutants that recovered from the high
dosetreatmentweresubjected tocolonysizinganalysis.
Both trials produced a preponderance of small colony
mutants, suggesting that the primary type of damage
induced may have been chromosomal aberrations.
Some of the hydrolysis products of MIC were also
tested in this assay. N,N'-dimethylurea gave negative
resultsinthepresenceandabsenceofratliverS9. Meth-
ylamine was mutagenic in two trials in the absence of
S9, but effects were seen only at 200 to 300 nL/mL,
whereas much higher mutant frequencies were seen
with MIC at 3 nL/mL. The ethyl ester ofN-methylcar-
bamic acid was shown to be weakly mutagenic in the
presence ofrat liver S9, givingno more than a doubling
ofthe mutant fraction at doses up to 5000 nL/mL (1).
CHO Cytogenetics
The induction of chromosomal aberrations and SCE
by MIC was assessed in cultured CHO cells in the pres-
ence and absence of Aroclor-1254 induced rat liver S9.
Tests for SCE induction were reproducibly positive
with and without S9 over a dose range from 0.3 to 3
,ug/mL. SCE induction occurred at doses of MIC that
resulted in extended cell cycles. Chromosomal aberra-
tion tests were conducted at doses ranging from ap-
proximately 10 to 25 ,ug/mL MIC. Test results were
positive both in the absence and presence ofS9. Again,
cell cycle delay occurred, and cells were harvested at
20 hr rather than the standard 12.5-hrharvest time (3).
Drosophila
Sex-linked recessive lethal tests were conducted in
Drosophila using three different routes of administra-
tionto exposemalesto MIC. MIC wastesteduptotoxic
doses by all three routes (feeding, inhalation, and in-
jection). MIC gave negative results under all conditions
used in these studies (3) (Table 1).
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Table 2. Summary of results from cytogenetic assays on mice
exposed to MIC by inhalation.
A. Bone marrow analyses: single 2-hr exposure to 0, 3, 10, or 30
ppm.
Sex Expt.# CA SCE AGT MN-PCE
M I 0 oa + 0
M II 0 oa + 0
B. Bone marrow, blood, and lung analyses: 4-day (6 hr/day)
exposure regimen.
Peripheral
blood Ln Bone marrow Lung
MIC MN- SCE- Cells
Sex Expt.# (ppm) CA SCE AGT PCE PBL SCE
M I 0,1,3 0 + + 0
II 0,1,3 0 0 + 0
III 0,1,3 NS ob + 0 0
IV 0,1,3,6 + OC + + 0
F I 0,1,3 0 0 0 0 -
II 0,1,3 + 0 0 0
III 0,1,3 NS + 0 0 +
IV 0,1,3,6 + + + 0 +
CA = chromosomal aberration; SCE = sister chromatid exchange;
AGT = average generation time; MN = micronucleus; PCE = poly-
chromatic erythrocyte; PBL = peripheral blood lymphocyte. NS =
nonscorable; 0 = no significant difference; - = no data obtained; +
= significant difference at p S 0.05.
aHighest concentration tested was 10 ppm.
bHighest concentration evaluated was 1 ppm.
'Highest concentration evaluated was 3 ppm.
Mouse Bone Marrow Cytogenetics:
Chromosomal Aberrations (CA), SCE, and
Micronuclei (MN)
A series ofexperiments was conducted to assess the
abilityofMIC toinducechromosomal effects inthebone
marrow cells ofB6C3F1 mice exposed viainhalation (4).
Twoexposureregimenswereused. Inthefirstregimen,
two groups ofmale mice were exposed to 3, 10, and 30
ppm MIC for a single 2-hr period. In the second regi-
men, male and female mice were 'xposed to MIC for 6
hr a day on 4 consecutive days. Four experiments were
conducted using this regimen. The first three experi-
ments included test groups exposed to 1 and 3 ppm; a
6 ppm exposure group was included in the final 4-day
exposure experiment. Test results are presented in Ta-
ble 2. For details on exposure, see Adkins et al. (5).
The 2-hour exposure of male mice at 3, 10, and 30
ppmdidnotsignificantly affectfrequencies ofCA, SCE,
or MN in the bone marrow. The only significant bone
marrow effect in these two experiments was a marked
increase in the cell cycle time. In the 30 ppm groups,
cell cycle times were estimated to be more than twice
the normal 11 to 13 hr-cycle.
In the four, 4-day exposure experiments, bone mar-
row cell cycle delay was again evident in treated males.
Only in the final experiment, which included a 6 ppm
exposure group, was this effect seen in females.
Significantly elevated frequencies of CA occurred in
both sexes in the 4-day exposure experiment that in-
cluded the 6 ppm group, and in females an elevated
chromosomal aberration frequency was seen in one ear-
lier 4-day exposure experiment at 3 ppm. SCE fre-
quencies were significantly elevated in females in two
experiments, including the experiment with the 6 ppm
group. An increase in SCE frequency was also found in
males in the first 4-day exposure experiment, but sub-
sequent experiments were negative. These negative re-
sults may be attributable to the fact that, due to cell
cycle delays, the high dose groups of males could not
be scored for SCE in the third and fourth experiments
because there were no (or inadequate) second division
cells to score.
The frequency of MN polychromatic erythrocytes
(PCE) and normochromatic erythrocytes in the periph-
eral blood was determined in both sexes in all 4-day
experiments. The only significant elevation in incidence
ofmicronucleated cells was in the MN-PCE ofmales in
the6ppmgroupofthelastexperiment. Table2presents
a summary of cytogenetic results.
SCE in Mouse Lung Cells and Peripheral
Blood Lymphocytes (PBL)
Groups of mice were included in two experiments to
conduct SCE studies on PBL and primary lung cells
obtained by perfusion with trypsin, EDTA, and colla-
genase (Table 2). Because oftechnical difficulties, final
results were limited to lungcells from females and PBL
from males. In both experiments with cultured lung
cells, a dose-related significant elevation in SCE was
observed. SCE results from PBL determinations were
uniformly negative when compared to the concurrent
controls. It was noted that in both experiments, leu-
kocyte counts were significantly reduced in the high
dose groups (2).
Discussion
Asacarbamoylating agent(R-N=C=0), MICmight
be expected to react with nucleophilic sites on cellular
macromolecules, including proteins, RNA, and DNA.
Isocyanates have been studied to a very limited extent
inbiologicalsystems, because oftheirextremevolatility
and toxicity. One report was found on the direct inter-
action between nucleic acid bases and isocyanates (6),
where carbamoylation ofboth endocycic and exocyclic
nitrogens were reported. Most ofthe literature on car-
bamoylation ofnucleic acids and proteins has come from
studies of dialkylnitrosoureas that have been proposed
or used as cancer chemotherapeutic agents. These com-
pounds are known to decompose under physiological
conditions to yield alkylating and carbamoylating moie-
ties, the latter being an isocyanate (7,8).
The carbamoylation of proteins by alkylnitrosoureas
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is well established (9-11). Carbamoylation by dialkyl-
nitrosoureas has also been reported for DNA and RNA
bases (12), DNAand polynucleotides (12-14), and RNA
(15). With respect to the possible mutagenic effects of
carbamoylation, a key set ofexperiments was reported
on the binding of1-(2-chloroethyl)-3-cyclohexyl-1-nitro-
sourea (CCNU) to nucleic acids andproteins (10). Using
CCNU labeled in either the ethylene or cyclohexyl
group, Cheng et al. determined the relative binding of
these two groups to isolated nucleic acids and proteins,
to nucleic acids and proteins in cultured L1210leukemia
cells, and to proteins and nucleic acids in L1210 leu-
kemia-bearing mice. With all three experimental con-
ditions, the labeled ethyl group was found to bind ex-
tensively to both nucleic acids and proteins, while the
labeled cyclohexyl moiety, presumably present as a cy-
clohexylcarbamoylgroup, was bound almostexclusively
to protein.
A case can be made that the genetic toxicity ofMIC
reported in this paper might be due in whole or in part
to MIC disruption of the integrity of eukaryotic chro-
mosomes through interaction with nuclear proteins. Al-
though speculative, this possibility is supported by re-
ports that alkylnitrosoureas lead to carbamoylation of
the chromatin (16,17) and the nuclear matrix (18).
The negative results obtained with MIC in the Sal-
monella and Drosophila assays suggest that MIC may
not induce base pair changes in DNA. The positive re-
sults in the L5178Y mouse lymphoma cell assay, an
assayoriginally designed to detectgenemutations, may
reflect the capacity of this assay to detect trifluoro-
thymidine-resistant mutants that have lost thymidine
kinase activity as the result ofchromosomal rearrange-
ments; a mechanism for which evidence has been pub-
lished (19). The other assays, including the in vitro cy-
togenetics test in CHO cells and the in vivo studies on
inhalation-exposed mice, all rely on chromosomal end-
points-aberrations, micronuclei, and sister-chromatid
exchanges.
In conclusion, MIC gave negative results in the Sal-
monella/mammalian microsome assay and the Droso-
phila sex-linked recessive lethal test, but was found to
increase the frequency of aberrations and SCE in cul-
tured CHO cells andtrifluorothymidine-resistant clones
in cultured L5178Y cells. In mice exposed to MIC by
inhalation for 4 days, there were increases in chromo-
somal aberrations, SCE, and micronuclei in bone mar-
row cells, and increased SCE frequencies in lung cells
but not in peripheral blood lymphocytes. It is notewor-
thy that no cytogenetic effects were observed in the
bone marrow of mice exposed for 2 hr to near lethal
dosesofMIC. However, MIC wasfoundtoreproducibly
delay bone marrow cell cycle time in male mice sub-
jected to single or multiple exposures.
These results, from both in vitro and in vivo tests,
provide convincing evidence that MIC is capable of in-
ducing chromosomal damage, and that this genetic tox-
icity is not strongly expressed in vivo, perhaps because
of the selective reactivity of MIC with proteins. Al-
though carbamoylation of DNA has been implicated in
the induction ofmutations (14), based on what is known
about the binding of isocyanates to cellular macromo-
lecules, theinterestingpossibilitythatthe chromosomal
effects ofMIC reported here may result from the bind-
ing ofMIC to DNA-associated proteins rather than di-
rectly to DNA cannot be ruled out.
The research described in this article has been reviewed by the
Health Effects Research Laboratory, U.S. Environmental Protection
Agency and approved for publication. Approval does not signify that
the contents necessarily reflect the views and policies ofthe Agency
nor does mention of trade names or commercial products constitute
endorsement or recommendation for use.
REFERENCES
1. Caspary, W. J., and Myhr, B. Mutagenicity ofmethyl isocyanate
and its reaction products to cultured mammalian cells. Mutat.
Res. 174: 285-293 (1986).
2. Kligerman, A. D., Campbell, J. A., Erexson, G. L., Allen, J. W.,
and Shelby, M. D. Sister chromatid exchange analyses in lung
and peripheral blood lymphocytes of mice exposed to methyl is-
ocyanate by inhalation. Environ. Mutagen. 9: 29-36 (1986).
3. Mason, J. M., Zeiger, E., Haworth, S., Ivett, J., and Valencia,
R. Genotoxicity studies ofmethyl isocyanate in Salmonella, Dro-
sophila, and cultured Chinese hamster ovary cells. Environ. Mu-
tagen. 9: 19-28 (1987).
4. Tice, R. R., Luke, C. A., and Shelby, M. D. Methyl isocyanate:
An evaluation ofin vivo cytogenetic activity. Environ. Mutagen.
9: 37-58 (1987).
5. Adkins, B. Jr., O'Conner, R. W., and Dement, J. M. Inhalation
exposure system used for acute and repeated-dose methyl iso-
cyanate exposures of laboratory animals. Environ. Health Per-
spect. 72: 45-51 (1987).
6. Dutta, S. P., and Chheda, G. B. Synthesis and properties ofN-
carbamoyl derivatives ofcytosine, cytidine, uracil, and thymine.
J. Carbohydr. Nucleosides Nucleotides 7: 217-240 (1980).
7. Montgomery, J. A., James, R., McCaleb, G. S., and Johnson, T.
P. The modes of decomposition of 1,3-bis(2-chloroethyl)-1-nitro-
soureaand related compounds. J. Med. Chem. 10: 668-674 (1967).
8. Kann, H. E., Jr. Carbamoylating activity of nitrosoureas. In:
Nitrosoureas: Current Status and New Developments (A. W.
Prestayko, S. T. Crooke, L. H. Baker, S. K. Carter, and P. S.
Schein, Eds.), Academic Press, New York, 1981, pp. 95-105.
9. Bowdon, B. J., and Wheeler, G. P. Reaction of 1,3-bis(2-chloroe-
thyl)-1-nitrosourea (BCNU) with protein. Proc. Am. Assoc. Can-
cer Res. 12: 67 (1971).
10. Cheng, C. J., Fujimura, S., Grunberger, D., and Weinstein, I.
B. Interaction of 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea
(NSC 79037) with nucleic acids and proteins in vivo and in vitro.
Cancer Res. 32: 22-27 (1972).
11. Schmall, B., Cheng, C. J., Fujimura, S., Grunberger, D., and
Weinstein, I. B. Modification of proteins by 1-(2-chloroethyl)-3-
cyclohexyl-1-nitrosourea. Proc. Am. Assoc. Cancer Res. 13: 65
(1972).
12. Serebryani, A. M., and Randalu, K. A. Carbamoylation of DNA
bases using N-methy-N-nitrosourea. Bioorg. Khim. 3: 633-638
(1977).
13. Serebryani, A. M., Smotryaeva, M. A., Kruglyakova, K. E., and
Kostyanovskii, R. G. Carbamoylation of DNA by N-nitroso-N-
methylurea. Dokl. Akad. Nauk SSSR 185: 847-849 (1969).
14. Skipper, P. L., Tannenbaum, S. R., Thilly, W. G., Furth, E. E.,
and Bishop, W. W. Mutagenicity of hydroxamic acids and the
probable involvement of carbamoylation. Cancer Res. 40: 4704-
4708 (1980).
15. Serebryani, A. M., Tutlite, V., Slavenas, J., and Kostyanovskii,
R. G. Identification of the products of RNA carbamoylation by
N-nitroso-N-methylurea. Izv. Akad. Nauk SSSR Ser. Khim. 5:
1189 (1973).GENETIC TOXICITY OF METHYL ISOCYANATE 187
16. Sukhakar, S., Tew, K. D., Schein, P. S., Woolley, P. V., and
Smulson, M. E. Nitrosoureainteractionwithchromatinandeffect
on poly(adenosine diphosphate ribose)polymerase activity. Can-
cer Res. 39: 1411-1417 (1979).
17. Jump, D. B., Sukhakar, S., Tew, K. D., and Smulson, M. Probes
to study the effect of methyl nitrosourea on ADP-rebosylation
and chromatin structure at the subunit level. Chem-Biol. Inter-
act. 30: 35-52 (1980).
18. Tew, K. D., Wang, A. L., and Schein, P. S. Alkylating agent
interactions with the nuclear matrix. Biochem. Pharmacol. 32:
3509-3516 (1983).
19. Hozier, J., Sawyer, J., Moore, M., Howard, B., and Clive, D.
Cytogenetic analysis ofthe L5178Y TK ' - TK-'- mouse lym-
phoma mutagenesis assay system. Mutation Res. 84: 169-181
(1981).